Homepage English
Homepage Nederlands
Contact
Organisation
Research
Events
Clinical Research Bureau
Links
Funding
Portfolio
PEG-IFN HBV Treatment Index

Investigator Initiated international multi-center studies 1990-2011:

  • Benelux HCV 90-01(3 countries)
  • Eurohep HBV 91-01 (5 countries / 154 patients)
  • Benelux HCV 96-01(3 countries / 300 patients)
  • Eurohep retrospective studies 1990 - 1999 (5 countries)
  • HBV 99-01(9 countries / 30 centers / 304 patients)
  • SNMC HCV phase I + II (4 countries / 7 centers / 120 patients)
  • MAIPD SNMC (12 centers / 1093 patients)
  • Ditto HCV study (9 countries / 9 centers / 273 patients)
  • PARC HBV study (7 countries / 25 centers / 138 patients)
  • Long term FU HBV 99-01 (9 countries / 30 centers / 163 patients)
  • ARES study (5 countries / 20 centers / 180 patients)


Investigator Initiated national studies 1990-2011:

  • National PBC cohort (335 patients)
  • POPS HCV study (80 patients)
  • SCIN-C HCV study (30 patients)
  • ADAFI IBD study (146 patients)
  • Virid study (127 patiens)
  • LOL3 study ( 96 patients)
  • PADD study ( 30 patients)

Publications from 2000-2011 in following journals:

  • Lancet
  • New England Journal of Medicine
  • Annals of Internal Medicine
  • Blood
  • Gastroenterology
  • Hepatology
  • Gut
  • Journal of Hepatology
  • American Journal of Gastroenterology
  • Gastrointestinal Endoscopy
  • Liver Transplantation
  • Journal of Viral Hepatitis
  • Alimentary Pharmacology & Therapeutics
  • Nature Clinical Practice Gastroenterology

 

 
Contact information
Foundation for Liver and Gastrointestinal Research
P/A Erasmus MC, Room Ha 204
Address
's Gravendijkwal 230
3015 CE Rotterdam
colofon - disclaimer